Thus, we hypothesize that IL-21 exhibits a biologically relevant and generally positive effect on circulating immune cells in patients with pancreatic cancer, associated with expansion of certain TCR specificities, such as specific mesothelin epitopes, described in this report. This evidence concerns the gene MSLN and familial pancreatic carcinoma.